Maternal tenofovir with Vaccination to prevent Vertical Hepatitis B transmission
Advertisement
This study was carried out by Ha T. Nguyen and colleagues to examine the efficiency and safety of pharmaceutical therapies to prevent vertical transmission of the hepatitis B virus.
Cochrane, Medline, and Scopus databases were searched for this study up to October 28th, 2020. All randomized controlled studies that reported vertical hepatitis B viral transmission with the pharmaceutical intervention were properly searched and included in the analysis. The Cochrane Risk-of-Bias tool Version 2 was used to assess the risk of bias. The effectiveness of the treatment was calculated using a stratified network meta-analysis which was based on maternal hepatitis B envelope antigen status.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.